AlleCure Corp., of Valencia, Calif., appointed Thomas Lobl vice president of research and development.
Amgen Inc., of Thousand Oaks, Calif., added Joseph Miletich as senior vice president, research and preclinical development.
Biogen Inc., of Cambridge, Mass., appointed John Palmer senior vice president, corporate development.
BioProcessors Corp., of Woburn, Mass., added Mike Pavia to its board.
Cellegy Pharmaceuticals Inc., of South San Francisco, added Michael Miller as vice president, commercial operations.
CuraGen Corp., of New Haven, Conn., elected David Ebsworth and John Forsgren to its board.
Genset SA, of Paris, appointed Marc Vasseur senior vice president.
Genta Inc., of Berkeley Heights, N.J., appointed Jean O’Connor vice president, quality assurance.
ICN Pharmaceuticals Inc., of Costa Mesa, Calif., appointed Robert Gelbard senior vice president for international affairs and government relations.
Immunomedics Inc., of Morris Plains, N.J., added Terence Rugg as chief medical officer and senior vice president.
Intronn Inc., of Rockville, Md., named its board, consisting of Michael Berendt, Holly Hagens, Christopher Martin, Christopher Pearce and Lloyd Mitchell.
LION bioscience AG, of Heidelberg, Germany, appointed Martin Hollenhorst chief financial officer.
Lipid Sciences Inc., of Pleasanton, Calif., appointed Deborah Lorenz vice president of investor relations and corporate communications.
Lipid Sciences Inc., of Pleasanton, Calif., named Hana Moran vice president of regulatory affairs.
Medinox Inc., of San Diego, added David King as vice president of corporate development.
Milkhaus Laboratory Inc., of Providence, R.I., elected John Friede to its board.
Morphochem AG, of Munich, Germany, appointed Eric Eastman president of Morphochem Inc., its U.S. operations.
Munich Biotechnology AG, of Martinsried, Germany, appointed Michael Witzel, Eric Stoer and Torsten Goesch to its supervisory board.
Novirio Pharmaceuticals Inc., of Cambridge, Mass., appointed John Dunphy chief financial officer.
Oncosis Inc., of San Diego, appointed Karin Eastham to its board.
Orthovita Inc., of Malvern, Pa., appointed Steven Lopez vice president, U.S. sales.
Perlegen Sciences Inc., of Mountain View, Calif., appointed Philip Sussman vice president of business development.
Pharmacor Inc., of Montreal, appointed Brian Conway chairman of its scientific advisory board.
Prima Biomed Ltd., of Melbourne, Australia, appointed Mark Hogarth nonexecutive director.
Protein Design Labs Inc., of Fremont, Calif., added Brett Schmidli as senior vice president, technical operations.
Titan Pharmaceuticals Inc., of South San Francisco, added Frank Valone as executive vice president of clinical development and regulatory affairs.
Vion Pharmaceuticals Inc., of New Haven, Conn., named Howard Johnson chief financial officer.